SCHEMBL2774474

SCHEMBL2774474

CCCCCCCCCCCCCCCCC(CC(O)CO)C(=O)OO

nearest known ligand 0.47

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.47
KDM4E B2RXH2 1/20 0.47
DUSP3 P51452 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
GPR84 Q9NQS5 7/20 0.42
CA2 P00918 1/20 0.42
GRIK1 P39086 1/20 0.41
GRIK2 Q13002 1/20 0.41
DGKA P23743 1/20 0.41
FFAR1 O14842 2/20 0.41
FFAR4 Q5NUL3 1/20 0.41
USP2 O75604 1/20 0.41
ZDHHC7 Q9NXF8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4725452 1.00 LMNA (0.47) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL18036544 0.87 CA2 (0.54) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL28683368 0.87 KDM4E (0.47) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL28964248 0.87 KDM4E (0.47) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL28665390 0.87 CA2 (0.54) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL1173137 0.86 USP2 (0.47) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL14778639 0.86 USP2 (0.47) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL20917644 0.86 USP2 (0.47) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL170853 0.86 KDM4E (0.58) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL738730 0.86 USP2 (0.47) LMNAKDM4EDUSP3MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 181 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3532171-A1 CLEANSING COMPOSITIONS WITH CONDITIONING PROPERTIES L'Oreal (FR) 2019-09-04 EP claimed
US-10265261-B2 Cleansing compositions with conditioning properties L'OREAL (FR) 2019-04-23 US claimed
WO-2018080919-A1 CLEANSING COMPOSITIONS WITH CONDITIONING PROPERTIES L'OREAL (FR) 2018-05-03 WO claimed
US-20180116937-A1 CLEANSING COMPOSITIONS WITH CONDITIONING PROPERTIES L'OREAL (FR) 2018-05-03 US claimed
WO-2004090054-A1 GLAZING AND BEDDING COMPOSITIONS SPECIALISED TECHNOLOGIES LIMITED (NZ) 2004-10-21 WO claimed
US-5795695-A PHOTO-QUALITY RECORDING XEROX CORPORATION (US) 1998-08-18 US claimed
US-20250205143-A1 ADDITIVE FOR SUNSCREENS SYMRISE AG (DE) 2025-06-26 US disclosed
WO-2025137712-A1 COSMETIC COMPOSITIONS AND METHODS OF USING SAME MARY KAY INC. (US) 2025-06-26 WO disclosed
EP-4574217-A2 ADDITIVE FOR SUNSCREENS Symrise AG (DE) 2025-06-25 EP disclosed
US-12257330-B2 Hair coloring compositions and methods of use L'OREAL (FR) 2025-03-25 US disclosed
EP-4496476-A1 GAS PHASE TREATMENT OF PRODUCE Apeel Technology, Inc. (US) 2025-01-29 EP disclosed
EP-4493147-A1 ADDITIVE FOR SUNSCREENS Symrise AG (DE) 2025-01-22 EP disclosed
EP-4440531-A1 KIT AND METHOD FOR TREATING SKIN L'OREAL (FR) 2024-10-09 EP disclosed
WO-1995001384-A1 THERMOPLASTIC ELASTOMERIC COPOLYMERS AND HAIR AND SKIN CARE COMPOSITIONS CONTAINING THE SAME THE PROCTER & GAMBLE COMPANY (US) 1995-01-12 WO disclosed
EP-0559786-A1 LEAVE-ON FACIAL EMULSION COMPOSITIONS. RICHARDSON VICKS INC (US) 1993-09-15 EP disclosed
WO-1992009264-A2 LEAVE-ON FACIAL EMULSION COMPOSITIONS RICHARDSON-VICKS, INC. (US) 1992-06-11 WO disclosed
US-4143890-A MICROENCAPSULATION, DUPLICATION, CHROMOGENS THE MEAD CORPORATION (US) 1979-03-13 US disclosed
US-4139218-A NONAQUEOUS, SOLVENT-FREE HOT MELT ADHESIVE SUSPENSION OF MICROENCAPSULATED CHROMOGENS, POLARITY THE MEAD CORPORATION (US) 1979-02-13 US disclosed
US-4139392-A CARBONLESS COPYING THE MEAD CORPORATION (US) 1979-02-13 US disclosed
US-4137343-A Process for producing pressure-sensitive carbonless transfer sheets THE MEAD CORPORATION (US) 1979-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10265261-B2 Cleansing compositions with conditioning properties SGMS2, SGMS1, LIPG LMNA 2535/4885KDM4E 2094/4885DUSP3 4067/4885
US-12257330-B2 Hair coloring compositions and methods of use SGMS1, PHOSPHO1, SGMS2 LMNA 1805/4885KDM4E 3783/4885DUSP3 1241/4885
US-20250205143-A1 ADDITIVE FOR SUNSCREENS CUTA, BRCA1, SUN2 LMNA 1269/4885KDM4E 3602/4885DUSP3 4051/4885
US-20180116937-A1 CLEANSING COMPOSITIONS WITH CONDITIONING PROPERTIES SGMS2, SGMS1, LIPG LMNA 2535/4885KDM4E 2094/4885DUSP3 4067/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.